Physician profile
Edward Lee
NPI 1083029995
$14,195.54
in general payments reported to CMS, 2019-2025
24 companies · $2,294 in 2025
The $2,294 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,590 · 2020: $137 · 2021: $1,331 · 2022: $5,188 · 2023: $1,686 · 2024: $970 · 2025: $2,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,237 · Food and Beverage: $1,713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,236.59 |
| Food and Beverage | $1,712.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Summit Surgical Corp. | $3,672.65 | 2022-2024 | |
| Treace Medical Concepts, INC. | $3,258.06 | 2022-2024 | |
| Smith+Nephew, INC. | $1,824.86 | 2021-2025 | Tula, Grafix Pl, Collagenase Santyl |
| Stryker Corporation | $1,563.11 | 2020-2025 | Prostep, Augment Injectable, N/A |
| Medinc of Texas | $1,337.00 | 2019 | |
| Paragon 28, INC. | $1,182.93 | 2019 | |
| Arthrex, INC. | $462.48 | 2023 | |
| Bone Support INC. | $144.46 | 2021 | |
| Organogenesis INC. | $142.00 | 2022-2025 | Puraply Wound Matrix, Puraply |
| Invictus Surgical Incorporated | $130.22 | 2024-2025 | |
| Fusion Orthopedics USA, LLC | $115.50 | 2025 | |
| Integra Lifesciences Corporation | $61.34 | 2019-2021 | |
| Horizon Therapeutics Plc | $48.47 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $41.61 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $37.78 | 2023-2025 | Jublia |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $29.39 | 2024 | Krystexxa |
| Orthofix Medical, INC. | $24.92 | 2024 | Physio-Stim |
| Abbvie INC. | $23.07 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $21.55 | 2022 | |
| Reprise Biomedical, INC. | $20.64 | 2025 | Mirotract |
| Next Science LLC | $19.10 | 2022 | |
| Nevro Corp. | $18.68 | 2023 | Senza |
| Merck Sharp & Dohme LLC | $13.44 | 2019 | |
| Advanced Oxygen Therapy INC. | $2.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.